Biological E. Limited

12 articles about Biological E. Limited

• Takeda and Biological E. Limited Collaborate to Accelerate Access to Dengue Vaccine in Endemic Areas

  2/27/2024

  Takeda and Biological E. Limited, a leading India-based Vaccines and Pharmaceutical Company, announced a strategic partnership to accelerate access to QDENGA®▼ multi-dose vials.

• Dynavax and Biological E Announce Commercial Supply Agreement of Dynavax's CpG 1018 Adjuvant for Biological E's COVID-19 Vaccine Candidate

  7/6/2021

  Biological E to purchase CpG 1018 adjuvant from Dynavax for use in the commercial production of Biological E's COVID-19 vaccine candidate, CORBEVAX™

• Texas Children's Hospital Center for Vaccine Development COVID-19 Subunit Vaccine Candidate Advancing Towards Global Access

  6/9/2021

  Texas Children's Hospital and Baylor College of Medicine leading COVID-19 subunit vaccine candidate, developed with Biological E. Limited, a Hyderabad-based vaccine and pharmaceutical company, has received approval to proceed with Phase III clinical trials in India.

• Biological E. Limited Starts Phase I/II Clinical Trial of its COVID-19 Vaccine Candidate

  11/16/2020

  Biological E. Limited, Dynavax Technologies Corporation, and Baylor College of Medicine announced that BE has initiated a Phase I/II clinical trial of its COVID-19 subunit vaccine candidate in India following approval from the Drugs Controller General of India.

• Takeda And Biological E. Limited Announce Partnership To Develop Low-Cost Combination Vaccines For Low- And Middle-Income Countries Around The Globe

  6/26/2017

• Biological E. Limited's Japanese Encephalitis Vaccine Prequalified by the World Health Organization

  7/22/2013

• Novartis AG, Biological E. Limited Join Hands for Typhoid, Paratyphoid Vaccines

  7/8/2013

• VaxInnate Corporation Licenses Recombinant H1N1 Pandemic Swine Flu Vaccine to Biological E. Limited; Vaccine Could Become Available for Use in India This Year

  1/12/2010

• Biological E. Limited Strengthens Management Team with Appointment of Senior Vice Presidents from Leading Global Pharmaceutical and Biotech Firms

  1/27/2009

• Biological E. Limited Names Experienced Biopharmaceutical Executive, Rayasam Prasad, as Chief Operating Officer for Global Biologics

  8/8/2008

• Itero Biopharmaceuticals Inks Partnership With Indian Biotechnology Firm, Biological E. Limited; Raises $21 Million Venture Financing

  6/11/2008

• Leading India Manufacturer Heparinex LLC and U.S. Companies Biological E. Limited and Choncept, LLC Sign Option/License Agreements

  3/11/2008